Caribbean Pharma and OTC Fieldwork for International Research Agencies: How HRG Executes Your In-Market Healthcare Studies

International research agencies commissioning pharmaceutical and OTC consumer studies in the Caribbean face a consistent problem: no viable local fieldwork partner. The Caribbean is not a market that global fieldwork networks cover reliably. Recruitment networks are thin, facility infrastructure is limited outside of the major capitals, and moderators with genuine healthcare consumer research experience in these markets are rare. Hope Research Group fills that gap. Since 1985, HRG has executed pharma and OTC fieldwork across the Caribbean and the United States for commissioning agencies based in the UK, North America, India, and France.

Why International Agencies Need a Dedicated Caribbean Fieldwork Partner

Caribbean pharma fieldwork is defined as the in-market execution of pharmaceutical and OTC consumer research studies across Caribbean territories, covering recruitment, moderation, data collection, and output delivery. A fieldwork partner refers to the local research firm that executes this work on behalf of an international commissioning agency, operating under the agency's study design and quality standards while managing all in-country logistics independently.

The Caribbean pharmaceutical and OTC consumer research market presents a specific challenge for international agencies. The region is commercially relevant: the broader Caribbean pharmaceutical market is valued at approximately USD 2.8 billion in 2024 (Statista, 2024), growing at 4.4% CAGR to an estimated USD 3.5 billion by 2029. Major OTC brands including Bayer AG, Haleon Group, Sanofi, Reckitt Benckiser, and Kenvue distribute across Caribbean markets. Multinational pharmaceutical companies with Caribbean operations require ongoing consumer insights, and increasingly, UK and North American healthcare research agencies are receiving briefs that require data from Jamaica, Trinidad and Tobago, and Barbados alongside broader multi-market studies.

The challenge is execution. Global fieldwork networks designed for Western European or North American markets do not have reliable Caribbean coverage. Online panels are undersized across most Caribbean markets, with low active respondent counts, high re-contact rates, and demographic skews that produce unrepresentative samples for consumer health studies. Attempting to execute Caribbean OTC or pharma fieldwork through a generic global fieldwork platform typically produces samples that fail basic quality checks on representativeness, incidence accuracy, and socioeconomic spread.

HRG's Caribbean fieldwork infrastructure is purpose-built for these markets. Recruitment networks built over four decades cover urban, peri-urban, and rural communities across Jamaica, Trinidad and Tobago, and Barbados. In Kingston, HRG operates CCTV-equipped focus group rooms with live streaming for remote observers. In Port of Spain and Bridgetown, HRG works with established facility partners to provide equipped group rooms with remote viewing configured for each study. Moderator teams include specialists in healthcare and consumer health topics who understand the cultural dynamics of Caribbean health conversations.

The HRG Agency Partnership Model: What International Agencies Actually Get

HRG operates as a subcontractor on agency-led projects. The model is straightforward: the commissioning agency owns the client relationship, project design, and final reporting. HRG owns all in-market activity. This division of responsibility is clear, and it is the same model used by the global fieldwork network operators, except HRG has genuine Caribbean capability rather than repackaged online panel access.

On a typical OTC consumer qualitative study across three Caribbean markets, HRG's scope of work includes the following. Recruitment: HRG receives the agency screener, adapts it for Caribbean market realities if needed, and executes recruitment through its proprietary respondent network. Unlike online panel providers, HRG recruitment for Caribbean health studies uses telephone pre-screening, in-person or WhatsApp-based recruitment, and community network referrals, all methods that reliably access the general Caribbean population rather than the panel-active minority.

Facilities: HRG manages focus group delivery across Kingston (Jamaica), Port of Spain (Trinidad and Tobago), and Bridgetown (Barbados). In Kingston, HRG's own CCTV-equipped facility includes a waiting area, viewing room, and webcam streaming for remote observers. In Port of Spain and Bridgetown, HRG works with vetted facility partners and configures remote viewing and live streaming for each study, giving agency and client observers the same remote access. HRG can also deliver in-home IDIs and webcam depth interviews for studies where physical facility attendance creates access barriers for the target segment.

Moderation: HRG's qualitative team includes moderators with specific experience in OTC consumer research, healthcare decision-making studies, and sensitive health topic facilitation. Where agencies have a preference for agency-employed moderators, HRG can provide co-moderation or observer-level support in market. All moderation produces verbatim transcripts; HRG does not substitute summaries for full transcripts on agency-commissioned qualitative work.

Incentive management: HRG handles all participant incentive administration from pre-agreed incentive rates, paying respondents according to local market norms and maintaining full payment reconciliation documentation for agency reporting requirements.

Which Pharma and OTC Consumer Segments HRG Can Recruit in the Caribbean

Caribbean OTC consumer recruitment is HRG's standard capability. The segments below represent the most common requirements on agency-commissioned pharma and OTC studies. All incidence estimates are indicative; HRG provides project-specific incidence rates during proposal development based on current screener specifications.

Delivering Pharma and OTC Fieldwork Across the Three Primary Caribbean Markets

Jamaica: HRG's Largest Caribbean Fieldwork Operation

Jamaica is HRG's primary fieldwork market, with the deepest recruitment network and the most established facility infrastructure. Kingston and Montego Bay are the primary fieldwork centres for pharma and OTC studies, with Spanish Town and St. Andrew accessible for studies requiring geographic spread. The Fontana Pharmacy chain, with approximately 30 outlets, and Island Pharmacy Group provide natural intercept environments for CAPI studies targeting active OTC purchasers.

Jamaica's pharmaceutical market is projected at USD 102.9 million in 2025, growing to USD 120.5 million by 2029 (Statista, 2024). The consumer health landscape is shaped by the National Health Fund's subsidised chronic disease medication scheme, which creates a two-tier market: NHF-registered consumers managing chronic conditions through subsidised prescriptions, and the broader general population making fully out-of-pocket OTC decisions. Research designs for Jamaican pharma studies should account for this market structure difference in screener design and discussion guide construction.

Trinidad and Tobago: High-Value Consumer, Multi-Cultural Dynamics

Trinidad and Tobago offers HRG's second-largest Caribbean recruitment base, with a consumer profile distinguished by higher purchasing power and meaningful ethnic community variation. Guardian Pharmacy is the primary retail pharmacy chain for CAPI intercept work; Bhagan's and independent pharmacies extend coverage into community markets.

The multicultural composition of Trinidad and Tobago creates genuine segmentation opportunities for pharma and OTC research. Indo-Trinidadian and Afro-Trinidadian communities show statistically meaningful differences in attitudes toward herbal versus conventional OTC remedies, brand trust hierarchies, and pharmacist consultation behavior. For agencies running multi-country studies that include Trinidad, HRG recommends ethnic community quotas in the recruitment specification to ensure the Trinidadian sample is analytically useful at subgroup level.

Trinidad and Tobago's per capita health expenditure is projected to grow by 276% between the 2018-2019 baseline and 2050, the highest trajectory of any Caribbean nation in PAHO's longitudinal health expenditure model (Lancet LAC, 2024). This positions the market as a priority for pharma brands planning long-horizon Caribbean investment.

Barbados: Eastern Caribbean Benchmark and High-Sophistication Consumer

Barbados serves a distinct function in Caribbean pharma fieldwork: it is the Eastern Caribbean quality benchmark market. With approximately 287,000 residents and high consumer sophistication relative to market size, Barbados provides a high-literacy, high-health-awareness comparison point for interpreting results from larger, more economically varied markets like Jamaica. The island's strong UK historical ties mean British OTC brand familiarity is measurably higher than in other Caribbean markets, making Barbados particularly useful for studies being run by UK healthcare research agencies.

UniPharm is the primary pharmacy retail chain in Barbados. The public Drug Service Barbados handles subsidised medication for eligible chronic disease patients. Barbados participates actively in CARICOM's Caribbean Regulatory System (CRS) and PAHO's Caribbean Health Financing Framework, making it well-positioned for research touching on regulatory, pricing, or healthcare access dimensions of OTC consumer behavior.

Quality Standards and Compliance on HRG Agency Pharma Studies

Agency clients operating under ISO 20252 or ESOMAR codes of conduct can confirm the following quality provisions apply to all HRG pharma and OTC fieldwork. Recruitment validation: all respondents are pre-screened by telephone or structured in-person interview before placement on any study. HRG does not use online recruitment panels as the primary method for Caribbean pharma fieldwork; the panel populations across Caribbean markets are too small to support reliable incidence-based sampling for health category research.

Informed consent: all participants receive a verbal and written explanation of the research purpose (at category level, without disclosing the end client), their right to withdraw, and the handling of their responses. Consent is obtained and documented before any recording commences.

Data security: audio and video recordings are stored on encrypted systems. Transcripts are anonymized before delivery. HRG operates under a data processing agreement aligned with GDPR provisions for agency clients with European data processing obligations.

HRG has delivered fieldwork under agency commission for research organizations including Kantar, Consumer Insight Group, Mercaplan, Ipsos, Nielsen, and GfK. This track record provides a verifiable compliance reference for agency procurement teams assessing HRG as a fieldwork supplier.

Practical Logistics: Timelines, Briefing Process, and Proposal Format

The briefing process for pharma and OTC fieldwork with HRG follows a standard agency subcontractor workflow. Agencies submit a project brief covering study objectives, target segment, screener specifications or a draft screener, methodology (FGD, IDI, CAPI, or mixed), required sample sizes by market, field dates or preferred field window, output format requirements (transcripts, recordings, raw data), and any reporting requirements.

HRG returns a detailed cost proposal within 24 hours for standard studies and within 48-72 hours for complex multi-market or specialist segment briefs. The proposal includes itemized costs for recruitment, incentives, facilities, moderation, project management, and any travel costs. All proposals are in USD. Payment terms for agency clients are 50% upon project confirmation and 50% upon completion of fieldwork and delivery of agreed outputs.

How International Research Agencies Commission Caribbean Pharma Fieldwork: Step by Step

Step one is the project brief. Agencies send a brief to HRG covering the study objectives, target segments, screener specification, methodology, field dates, and output requirements. HRG accepts briefs by email and responds to confirm receipt and estimated proposal return time within two hours during working hours.

Step two is the HRG proposal. Within 24 hours, HRG returns a detailed cost proposal in USD with itemized line items, recommended field schedule, incidence estimates by market, and any questions on the brief that require agency clarification before confirmation.

Step three is project confirmation. Upon agency approval and deposit payment (50%), HRG begins recruitment. The agency receives a recruitment tracker update every 48 hours during the active recruitment period, showing confirmed recruits, pending recruits, and any incidence issues that require screener adjustment.

Step four is fieldwork execution. HRG conducts all in-market activity: respondent management, facility setup, moderation or interview administration, and data collection. Agency observers can attend in-person or connect via live streaming. HRG provides a daily field report on completion rates and any material issues.

Step five is output delivery. HRG delivers transcripts, recordings, and raw data files in agreed formats within the timeframes stated in the proposal. CAPI data is delivered as a clean CSV or SPSS dataset. Qualitative outputs include verbatim transcripts with respondent codes, audio or video files as specified, and a recruitment summary showing confirmed respondent profiles against screener criteria.

To begin the briefing process, contact HRG's agency fieldwork team directly or request a proposal through the site. For agencies that have worked with HRG before, the returning client process is streamlined through a standing data processing agreement and pre-approved agency terms.

Regulatory Context for Pharma and OTC Consumer Research in the Caribbean

Caribbean pharmaceutical regulation is governed at two levels: national medicines authorities in each country, and the regional harmonization framework administered through the Caribbean Regulatory System (CRS) and the Caribbean Public Health Agency (CARPHA). In December 2020, CARPHA signed a formal information-sharing agreement with PAHO/WHO to coordinate pharmaceutical product monitoring and post-market surveillance across member states.

Consumer research does not require regulatory approval from the CRS or CARPHA, as it falls outside the clinical trial and product registration frameworks these bodies govern. However, agencies commissioning studies that include stimulus testing of unregistered or in-development OTC products should confirm the regulatory status of any products being tested in Caribbean markets, as advertising or promotional stimulus for unregistered products may create compliance considerations in certain markets.

PAHO's 2024 Caribbean health financing data confirms that out-of-pocket spending represents approximately 31% of total Caribbean health expenditure, with public health spending at 3.6% of GDP. This context is relevant for research designs examining price sensitivity, switching behavior, and the decision between branded and generic OTC products. The full Caribbean pharmaceutical market analysis is available on the HRG blog.

Frequently Asked Questions: Caribbean Pharma Fieldwork for Agencies